MedDataX Logo

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A

NCT06223867 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 670

Last updated 2026-02-20

No results posted yet for this study

Summary

This Study will comprehensively evaluate a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs). The EBPs satisfy several key performance elements for systems adopting Zero Suicide.

A Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Study Design (CREID) will be used

Conditions

  • Suicidal Ideation
  • Suicide Attempt
  • Self Harm

Interventions

DEVICE

Jaspr App + JAH

With assistance form a research coordinator, the subject will complete self-administered suicide risk assessment on the tablet via Jaspr app, then the subject will engage with suicide-related coping skills and resources that the app provides. Subject will continue to have access to the coping skills and videos via a mobile app after discharge.

BEHAVIORAL

ETAU

Usual care for suicidal patients at UMass Memorial ED that may include Behavioral health evaluation by a trained clinician. Environmental safety precautions. Personalized safety upon discharge

Sponsors & Collaborators

  • Ohio State University

    collaborator OTHER

  • Evidence-Based Practice Institute, Seattle, WA

    collaborator INDUSTRY

  • Worcester Polytechnic Institute

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Colorado, Denver

    collaborator OTHER

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Edwin D Boudreaux, PhD · University of Massachusetts, Worcester

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-23
Primary Completion
2028-03-31
Completion
2028-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06223867 on ClinicalTrials.gov